Discover 3,086 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,086
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
for
Diabetes Mellitus, Type 2
Location: Boston MA
Sponsor: Joslin Diabetes Center
Sex: All
Age: 40+
Code: NCT05826678
Recruiting
New
Multicenter Study for External Validation of the TB-NET Score
for
Tumor Burden, Neuroendocrine (NE) Tumors
Location: Boston MA
Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Sex: All
Age: 18+
Code: NCT07903532
Recruiting
New
SMARCA4/2 Inhibitor for POU2F3-Positive SCLC
for
Small Cell Lung Cancer
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT07551635
Phase 2, Recruiting
New
Reach and Engagement of GENetic Education, Risk Assessment, and TEsting Feasibility Trial
for
Pancreatic Ductal Adenocarcinoma (PDAC),
Location: Boston MA
Sponsor: Brigham and Women's Hospital
Sex: All
Age: 18+
Code: NCT07787156
Recruiting
Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Boston MA, New York NY, Washington D.C. DC, Detroit MI,
Sponsor: OncoC4, Inc.
Sex: All
Age: 18+
Code: NCT06635785
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Boston MA, Horsham PA, Philadelphia PA, Rochester NY,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06369285
Phase 2, Recruiting
Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
for
Small Cell Lung Cancer
Location: Boston MA, Hackensack NJ, Buffalo NY, Chicago IL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06780137
Phase 1, Phase 2, Recruiting
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
for
Multiple Myeloma, Myeloma, Myeloma Multiple
Location: Boston MA, Hackensack NJ, New York NY, Philadelphia PA,
Sponsor: K36 Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05651932
Phase 1, Recruiting
Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia
for
T-Cell Large Granular Lymphocyte Leukemia
Location: Boston MA, New York NY, Columbus OH
Sponsor: Jonathan Brammer
Sex: All
Age: 18+
Code: NCT05592015
Phase 2, Recruiting
A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
for
Mature B-Cell Non-Hodgkin Lymphoma
Location: Boston MA, New York NY, Baltimore MD, Cincinnati OH,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 0 - 30
Code: NCT05533775
Phase 1, Phase 2, Recruiting
Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma
for
Relapsed Neuroblastoma, Refractory Neuroblastoma,
Location: Boston MA
Sponsor: Roberto Chiarle
Sex: All
Age: 1 - 29
Code: NCT06803875
Phase 1, Phase 2, Recruiting
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
for
Advanced Solid Tumor, Non Small Cell Lung Cancer,
Location: Boston MA, New Haven CT, Lake Success NY, New York NY,
Sponsor: Synthekine
Sex: All
Age: 18+
Code: NCT05098132
Phase 1, Phase 2, Recruiting
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors